Polymer Capital Management US LLC purchased a new stake in shares of The Clorox Company (NYSE:CLX – Free Report) during the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 3,945 shares of the company’s stock, valued at approximately $641,000.
Several other hedge funds and other institutional investors have also modified their holdings of the company. Norges Bank acquired a new position in Clorox in the 4th quarter worth about $259,041,000. FMR LLC raised its position in Clorox by 75.4% during the fourth quarter. FMR LLC now owns 1,361,758 shares of the company’s stock valued at $221,163,000 after acquiring an additional 585,526 shares in the last quarter. ExodusPoint Capital Management LP grew its position in Clorox by 187.9% in the fourth quarter. ExodusPoint Capital Management LP now owns 698,900 shares of the company’s stock worth $113,508,000 after acquiring an additional 456,114 shares in the last quarter. Amundi increased its stake in shares of Clorox by 42.6% during the 4th quarter. Amundi now owns 1,032,283 shares of the company’s stock worth $165,816,000 after purchasing an additional 308,234 shares during the last quarter. Finally, Assenagon Asset Management S.A. raised its holdings in shares of Clorox by 302.0% during the 4th quarter. Assenagon Asset Management S.A. now owns 353,367 shares of the company’s stock valued at $57,390,000 after purchasing an additional 265,455 shares in the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of equities research analysts recently issued reports on the stock. StockNews.com cut shares of Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Evercore ISI increased their price objective on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Barclays reduced their target price on Clorox from $140.00 to $139.00 and set an “underweight” rating for the company in a report on Thursday, March 27th. DA Davidson lowered their price target on Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a report on Wednesday, February 5th. Finally, Royal Bank of Canada restated a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $159.00.
Clorox Stock Performance
NYSE:CLX opened at $143.76 on Monday. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The firm’s 50-day moving average is $150.06 and its 200-day moving average is $158.36. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The company has a market cap of $17.71 billion, a price-to-earnings ratio of 39.28, a PEG ratio of 2.62 and a beta of 0.45.
Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the prior year, the company posted $2.16 earnings per share. Equities research analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current year.
Clorox Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be issued a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.39%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox’s dividend payout ratio (DPR) is presently 133.33%.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More
- Five stocks we like better than Clorox
- What is a support level?
- Newsmax’s IPO Whiplash: Meme Stock Hype or Growth Potential?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Disney 2025 Shareholders: Major Updates for Investors
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Advance Auto Parts Stock: A Classic Rebound Play in the Making
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.